Business
VVT Med Signs Largest European Distribution Agreement to Date; Distributor Joins as Investor
Five-Year Agreement Represents Approximately CAD $2.3 Million in Minimum Purchase Commitments | Distributor Joins as Investor in the Company’s Ongoing Private PlacementVANCOUVER, BC, April 27, 2026 (GLOBE NEWSWIRE) -- VVT Med Inc. (TSXV: VVTM) ("VVT Med" or the "Company"), a leader in next-generation, minimally invasive, non-thermal, and non-tumescent ("NT-NT") solutions for venous disease, is pleased to announce that it has entered into its largest European distribution agreement to date, a str
About this update from Vvt Med Inc.
[{"type":"image","alt":"VVT Med Inc.","displaySize":"","headline":null,"caption":"VVT Med Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":123,"url":"https://media.zenfs.com/en/globenewswire.com/1ecc9757aa8409ba9e1ee8b9c8bc8c9f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/diX6V9U9qjwfEEuE.HrDMg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE3Mg--/https://media.zenfs.com/en/globenewswire.com/1ecc9757aa8409ba9e1ee8b9c8bc8c9f","width":300,"height":123}},"lazy":false},{"type":"text","content":"Five-Year Agreement Represents Approximately CAD $2.3 Million in Minimum Purchase Commitments | Distributor Joins as Investor in the Company’s Ongoing Private Placement","length":168,"tagName":"p"},{"type":"text","content":"VANCOUVER, BC, April 27, 2026 (GLOBE NEWSWIRE) -- VVT Med Inc. (TSXV: VVTM) ("VVT Med" or the "Company"), a leader in next-generation, minimally invasive, non-thermal, and non-tumescent ("NT-NT") solutions for venous disease, is pleased to announce that it has entered into its largest European distribution agreement to date, a strategic exclusive distribution partnership with Uber Ros S.p.A. ("Uber Ros") for the commercialization of its ScleroSafe® system in Italy, Vatican City and the Republic of San Marino (the "Territory").","length":582,"tagName":"p","attribs":{}},{"type":"text","content":"Under the terms of the agreement, signed on April 9th, 2026, Uber Ros will serve as the Company's exclusive distributor in the Territory. The five-year agreement represents approximately CAD $2.3 million in potential revenue to the Company, based on agreed minimum purchase commitments, with a portion structured under a pay-or-buy mechanism that provides a defined level of commercial commitment from the distributor, subject to the terms of the agreement.","length":461,"tagName":"p","attribs":{}},{"type":"text","content":"Italy is a significant and strategically important healthcare market, with a well-established network of vascular and phlebology specialists. The partnership with Uber Ros enables VVT Med to access this market through an experienced and committed local commercial partner, supporting physician education and product adoption across the Territory.","length":346,"tagName":"p","attribs":{}},{"type":"text","content":"ScleroSafe® is FDA-cleared and CE-marked, ...